At the request of the Government of Canada, CRISM is rapidly developing a series of six national guidance documents. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID‑19 pandemic. The guidance provided in these document is subject to change as new information becomes available and the landscape of the pandemic and public health responses evolve over time. Check this page often for updates and new resources.
Guidance documents, knowledge products, and feedback forms may be accessed here
